Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Rognoni

Showing results (121-130 of 130) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 130 results.
International Journal of Cardiology|December 2, 2019
Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelorMatteo Bianco, Fabrizio D'ascenzo, Sergio Raposeiras Roubin, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|October 6, 2019
Efficacy and Safety of Clopidogrel, Prasugrel and Ticagrelor in ACS Patients Treated with PCI: A Propensity Score Analysis of the RENAMI and BleeMACS RegistriesMattia Peyracchia, Andrea Saglietto, Carloalberto Biolè, et al.
American Heart Journal|December 7, 2019
Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: Insights from the BleeMACS and RENAMI registriesFabrizio D'Ascenzo, Carloalberto Biolè, Sergio Raposeiras-Roubin, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 13, 2019
P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projectsOvidio De Filippo, Fabrizio D'Ascenzo, Sergio Raposeiras-Roubin, et al.
Journal of the American College of Cardiology|April 30, 2021
ST-Segment Elevation Myocardial Infarction Following Transcatheter Aortic Valve ReplacementLaurent Faroux, Thibault Lhermusier, Flavien Vincent, et al.
Thrombosis and Haemostasis|January 7, 2021
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST StudyAugusto Di Castelnuovo, Simona Costanzo, Andrea Antinori, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 11, 2020
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST StudyAugusto Di Castelnuovo, Marialaura Bonaccio, Simona Costanzo, et al.
Journal of Healthcare Engineering|August 2, 2021
Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical ClusteringAugusto Di Castelnuovo, Alessandro Gialluisi, Andrea Antinori, et al.
Scientific Reports|November 27, 2020
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patientsMattia Bellan, Giuseppe Patti, Eyal Hayden, et al.
Disease Markers|May 31, 2021
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19Mattia Bellan, Danila Azzolina, Eyal Hayden, et al.
Pageof 13

Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
International Journal of Cardiology|December 2, 2019
Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelorMatteo Bianco, Fabrizio D'ascenzo, Sergio Raposeiras Roubin, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|October 6, 2019
Efficacy and Safety of Clopidogrel, Prasugrel and Ticagrelor in ACS Patients Treated with PCI: A Propensity Score Analysis of the RENAMI and BleeMACS RegistriesMattia Peyracchia, Andrea Saglietto, Carloalberto Biolè, et al.
American Heart Journal|December 7, 2019
Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: Insights from the BleeMACS and RENAMI registriesFabrizio D'Ascenzo, Carloalberto Biolè, Sergio Raposeiras-Roubin, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 13, 2019
P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projectsOvidio De Filippo, Fabrizio D'Ascenzo, Sergio Raposeiras-Roubin, et al.
Journal of the American College of Cardiology|April 30, 2021
ST-Segment Elevation Myocardial Infarction Following Transcatheter Aortic Valve ReplacementLaurent Faroux, Thibault Lhermusier, Flavien Vincent, et al.
Thrombosis and Haemostasis|January 7, 2021
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST StudyAugusto Di Castelnuovo, Simona Costanzo, Andrea Antinori, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 11, 2020
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST StudyAugusto Di Castelnuovo, Marialaura Bonaccio, Simona Costanzo, et al.
Journal of Healthcare Engineering|August 2, 2021
Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical ClusteringAugusto Di Castelnuovo, Alessandro Gialluisi, Andrea Antinori, et al.
Scientific Reports|November 27, 2020
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patientsMattia Bellan, Giuseppe Patti, Eyal Hayden, et al.
Disease Markers|May 31, 2021
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19Mattia Bellan, Danila Azzolina, Eyal Hayden, et al.
Pageof 13